Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Bailey

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Medicine|August 20, 2013
Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithmTimothy Bailey
Expert Review of Medical Devices|April 5, 2012
FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionalsTimothy Bailey, Carlos Campos
Journal of Diabetes Science and Technology|February 10, 2011
Guidelines for optimal bolus calculator settings in adultsJohn Walsh, Ruth Roberts, Timothy Bailey
Diabetes Technology & Therapeutics|December 17, 2009
New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag timeTimothy Bailey, Howard Zisser, Anna Chang
Journal of Diabetes Science and Technology|October 6, 2010
Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levelsJohn Walsh, Ruth Roberts, Timothy Bailey
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Expert Opinion on Drug Delivery|June 13, 2014
Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionalsAndreas Pfützner, Thomas Forst, Marcus Niemeyer, et al.
Diabetes, Obesity & Metabolism|April 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programmeLawrence Blonde, Timothy Bailey, Sean D Sullivan, et al.
Current Medical Research and Opinion|November 26, 2011
Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learningDaniel A Nadeau, Carlos Campos, Marcus Niemeyer, et al.
Bioinformatics (Oxford, England)|May 6, 2011
Improved similarity scores for comparing motifsEmi Tanaka, Timothy Bailey, Charles E Grant, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Medicine|August 20, 2013
Options for combination therapy in type 2 diabetes: comparison of the ADA/EASD position statement and AACE/ACE algorithmTimothy Bailey
Expert Review of Medical Devices|April 5, 2012
FlexTouch® for the delivery of insulin: technical attributes and perception among patients and healthcare professionalsTimothy Bailey, Carlos Campos
Journal of Diabetes Science and Technology|February 10, 2011
Guidelines for optimal bolus calculator settings in adultsJohn Walsh, Ruth Roberts, Timothy Bailey
Diabetes Technology & Therapeutics|December 17, 2009
New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag timeTimothy Bailey, Howard Zisser, Anna Chang
Journal of Diabetes Science and Technology|October 6, 2010
Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levelsJohn Walsh, Ruth Roberts, Timothy Bailey
The Journal of Family Practice|June 21, 2019
Real-world evidence in diabetes: relevance to clinical practiceLawrence Blonde, Timothy Bailey, Jodi Strong, et al.
Expert Opinion on Drug Delivery|June 13, 2014
Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionalsAndreas Pfützner, Thomas Forst, Marcus Niemeyer, et al.
Diabetes, Obesity & Metabolism|April 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programmeLawrence Blonde, Timothy Bailey, Sean D Sullivan, et al.
Current Medical Research and Opinion|November 26, 2011
Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learningDaniel A Nadeau, Carlos Campos, Marcus Niemeyer, et al.
Bioinformatics (Oxford, England)|May 6, 2011
Improved similarity scores for comparing motifsEmi Tanaka, Timothy Bailey, Charles E Grant, et al.
Pageof 6